Titlebook: Development of Antibody-Based Therapeutics; Translational Consid Mohammad A. Tabrizi,Gadi G. Bornstein,Scott L. Kla Book 2018Latest edition

只看該作者 · 發(fā)表于 2025-3-30 10:58:30

Gruppenargeted antibodies and the high potency of small-molecule drugs with the aim of achieving durable responses in patients. As application of highly potent small-molecule drugs can be limited by their undesirable toxicity, targeted delivery of highly potent small-molecule drugs to specific cells is int

只看該作者 · 發(fā)表于 2025-3-30 14:00:37

只看該作者 · 發(fā)表于 2025-3-30 19:28:35

只看該作者 · 發(fā)表于 2025-3-30 21:33:31

https://doi.org/10.1007/978-981-13-0496-5Monospecific concepts; Bi-specific constructs; Nanobodies; Immune-oncology; Cancer; Preclinical studies; C

只看該作者 · 發(fā)表于 2025-3-31 02:43:25

只看該作者 · 發(fā)表于 2025-3-31 08:10:21

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-24 19:28
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved